Anne-Laure Bignon

Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial

Laëtitia Dahan, Nicolas Williet, Karine Le Malicot et al. · Journal of Clinical Oncology · 2021 · 66 citations

Medicine, Oncology, Pharmacology +17

CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC)

David Sefrioui, Ludivine Beaussire, André Gillibert et al. · British Journal of Cancer · 2021 · 36 citations · Full text

Medicine, Oncology, Pathology +14

Multidisciplinary team meetings: are all patients presented and does it impact quality of care and survival – a registry-based study

Quentin Rollet, Véronique Bouvier, Grégoire Moutel et al. · BMC Health Services Research · 2021 · 26 citations · Full text

Medicine, Oncology, Cancer Epidemiology +12

PRODIGE 29-UCGI 26 (NEOPAN): A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic Carcinoma

Michel Ducreux, Romain Desgrippes, Yves Rinaldi et al. · Journal of Clinical Oncology · 2025 · 22 citations

Medicine, Oncology, Pharmacology +15

CA19.9 decrease >15% is a predictor of favourable outcome in patients treated for advanced pancreatic carcinoma: analysis of two independent cohorts

Lucie Laurent, David Sefrioui, Anne-Laure Bignon et al. · HPB · 2018 · 19 citations · Full text

Medicine, Oncology, Surgical Oncology +4